These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 17446235)
1. Assessment of the anti-obesity effects of the TNP-470 analog, CKD-732. Kim YM; An JJ; Jin YJ; Rhee Y; Cha BS; Lee HC; Lim SK J Mol Endocrinol; 2007 Apr; 38(4):455-65. PubMed ID: 17446235 [TBL] [Abstract][Full Text] [Related]
2. Robust Reductions of Excess Weight and Hyperphagia by Beloranib in Rat Models of Genetic and Hypothalamic Obesity. Elfers CT; Roth CL Endocrinology; 2017 Jan; 158(1):41-55. PubMed ID: 27849360 [TBL] [Abstract][Full Text] [Related]
3. Aspergillus, angiogenesis, and obesity: the story behind beloranib. Howland RH J Psychosoc Nurs Ment Health Serv; 2015 Mar; 53(3):13-6. PubMed ID: 25751824 [TBL] [Abstract][Full Text] [Related]
4. Effects of central and peripheral injection of leptin on food intake and on brain Fos expression in the Otsuka Long-Evans Tokushima Fatty rat with hyperleptinaemia. Niimi M; Sato M; Yokote R; Tada S; Takahara J J Neuroendocrinol; 1999 Aug; 11(8):605-11. PubMed ID: 10447798 [TBL] [Abstract][Full Text] [Related]
5. Running wheel activity prevents hyperphagia and obesity in Otsuka long-evans Tokushima Fatty rats: role of hypothalamic signaling. Bi S; Scott KA; Hyun J; Ladenheim EE; Moran TH Endocrinology; 2005 Apr; 146(4):1676-85. PubMed ID: 15625240 [TBL] [Abstract][Full Text] [Related]
6. Differential body weight and feeding responses to high-fat diets in rats and mice lacking cholecystokinin 1 receptors. Bi S; Chen J; Behles RR; Hyun J; Kopin AS; Moran TH Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R55-63. PubMed ID: 17409266 [TBL] [Abstract][Full Text] [Related]
7. Fumagillin reduces adipose tissue formation in murine models of nutritionally induced obesity. Lijnen HR; Frederix L; Van Hoef B Obesity (Silver Spring); 2010 Dec; 18(12):2241-6. PubMed ID: 20094042 [TBL] [Abstract][Full Text] [Related]
8. Development of obesity in the Otsuka Long-Evans Tokushima Fatty rat. Schroeder M; Zagoory-Sharon O; Shbiro L; Marco A; Hyun J; Moran TH; Bi S; Weller A Am J Physiol Regul Integr Comp Physiol; 2009 Dec; 297(6):R1749-60. PubMed ID: 19793959 [TBL] [Abstract][Full Text] [Related]
9. The Korean traditional medicine gyeongshingangjeehwan inhibits adipocyte hypertrophy and visceral adipose tissue accumulation by activating PPARalpha actions in rat white adipose tissues. Shin SS; Jung YS; Yoon KH; Choi S; Hong Y; Park D; Lee H; Seo BI; Lee HY; Yoon M J Ethnopharmacol; 2010 Jan; 127(1):47-54. PubMed ID: 19799979 [TBL] [Abstract][Full Text] [Related]
10. Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Bråkenhielm E; Cao R; Gao B; Angelin B; Cannon B; Parini P; Cao Y Circ Res; 2004 Jun; 94(12):1579-88. PubMed ID: 15155527 [TBL] [Abstract][Full Text] [Related]
11. Long-term effects of a fatty acid synthase inhibitor on obese mice: food intake, hypothalamic neuropeptides, and UCP3. Cha SH; Hu Z; Lane MD Biochem Biophys Res Commun; 2004 Apr; 317(2):301-8. PubMed ID: 15063757 [TBL] [Abstract][Full Text] [Related]
12. The effect of moxonidine on feeding and body fat in obese Zucker rats: role of hypothalamic NPY neurones. Bing C; King P; Pickavance L; Brown M; Ziegler D; Kaan E; Williams G Br J Pharmacol; 1999 May; 127(1):35-42. PubMed ID: 10369453 [TBL] [Abstract][Full Text] [Related]
13. A randomized, placebo-controlled trial of beloranib for the treatment of hypothalamic injury-associated obesity. Shoemaker A; Proietto J; Abuzzahab MJ; Markovic T; Malloy J; Kim DD Diabetes Obes Metab; 2017 Aug; 19(8):1165-1170. PubMed ID: 28261955 [TBL] [Abstract][Full Text] [Related]
14. Herbal composition Gambigyeongsinhwan (4) from Curcuma longa, Alnus japonica, and Massa Medicata Fermentata inhibits lipid accumulation in 3T3-L1 cells and regulates obesity in Otsuka Long-Evans Tokushima Fatty rats. Roh JS; Lee H; Woo S; Yoon M; Kim J; Park SD; Shin SS; Yoon M J Ethnopharmacol; 2015 Aug; 171():287-94. PubMed ID: 26068433 [TBL] [Abstract][Full Text] [Related]
15. Central transthyretin acts to decrease food intake and body weight. Zheng F; Kim YJ; Moran TH; Li H; Bi S Sci Rep; 2016 Apr; 6():24238. PubMed ID: 27053000 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of beloranib for weight loss in obese adults: a randomized controlled trial. Kim DD; Krishnarajah J; Lillioja S; de Looze F; Marjason J; Proietto J; Shakib S; Stuckey BGA; Vath JE; Hughes TE Diabetes Obes Metab; 2015 Jun; 17(6):566-572. PubMed ID: 25732625 [TBL] [Abstract][Full Text] [Related]
17. Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice. Lee EY; Kim YW; Oh H; Choi CS; Ahn JH; Lee BW; Kang ES; Cha BS; Lee HC Metabolism; 2014 Jun; 63(6):793-9. PubMed ID: 24684824 [TBL] [Abstract][Full Text] [Related]
18. S 23521 decreases food intake and body weight gain in diet-induced obese rats. Claret M; Corominola H; Canals I; Nadal B; Chavanieu A; Pfeiffer B; Renard P; Gorostiaga C; Delagrange P; Grassy G; Gomis R Obes Res; 2004 Oct; 12(10):1596-603. PubMed ID: 15536223 [TBL] [Abstract][Full Text] [Related]
19. A functional leptin system is essential for sodium tungstate antiobesity action. Canals I; Carmona MC; Amigó M; Barbera A; Bortolozzi A; Artigas F; Gomis R Endocrinology; 2009 Feb; 150(2):642-50. PubMed ID: 18845634 [TBL] [Abstract][Full Text] [Related]
20. Capsaicin-like anti-obese activities of evodiamine from fruits of Evodia rutaecarpa, a vanilloid receptor agonist. Kobayashi Y; Nakano Y; Kizaki M; Hoshikuma K; Yokoo Y; Kamiya T Planta Med; 2001 Oct; 67(7):628-33. PubMed ID: 11582540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]